Reserpine

An alkaloid anti-hypertensive agent.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
2
AI-suggested references
0
Clinical trials

General information

Reserpine is an alkaloid which acts as an adrenergic uptake inhibitor with antihypertensive effects (NCIt).

Reserpine on DrugBank
Reserpine on PubChem
Reserpine on Wikipedia


Marketed as

APOPLON; HISERPIA; NOVORESERPINE; RESERFIA; RESERPINE; SERPALAN; SERPANRAY; SERPASIL

 

Structure image - Reserpine

CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC


Supporting references

Link Tested on Impact factor Notes Publication date
Kinetic characterization and inhibitor screening for the proteases leading to identification of drugs against SARS-CoV-2
3CLpro PapainLpro Small molecule Enzyme assay In vitro
in vitro enzyme assay; Vero E6 cells 4.92

The compound inhibited the SARS-CoV-2 Papain-like protease in a dose-dependent manner in vitro. It protected Vero E6 cells from viral infection with EC50 of 6.6 μM and SI of >15.2. It was determined to be active only when applied at both the pre- and post-entry stages of infection.

Feb/01/2021

AI-suggested references